Authors


Craig Wakeford, MA

Latest:

Reconsidering the Economic Value of Multiple Sclerosis Therapies

Availability of multiple sclerosis (MS) therapies provides substantial value to the currently healthy (who may contract MS in the future), particularly when treatment is fully covered by insurance.




Karen Quigley, MPH

Latest:

A Strategic Plan for Integrating Cost-effectiveness Analysis Into the US Healthcare System

A panel composed of medical and pharmacy directors expressed strong support for a greater role for cost-effectiveness analysis in US health policy decisions.



Harman Rahal

Latest:

Trends in Viral Hepatitis Cost-Effectiveness Studies

Regardless of the cause of bias, more awareness and scrutiny are needed when utilizing cost-effectiveness studies for healthcare decision making.


Kenneth M. Shermock, PharmD, PhD

Latest:

Limited Distribution Networks Stifle Competition in the Generic and Biosimilar Drug Industries

A limited distribution network is a pharmaceutical distribution strategy that some drug companies have capitalized upon to obstruct generic and biosimilar competition.


Ann Scheck McAlearney, ScD, MS

Latest:

Addressing Evolving Patient Concerns Around Telehealth in the COVID-19 Era

With a rapid shift to telehealth during the coronavirus disease 2019 (COVID-19) pandemic, clinicians, health care organizations, and policy makers must consider and address patients’ evolving needs, concerns, and expectations.






R. James Dudl, MD

Latest:

Preventing Myocardial Infarction and Stroke With a Simplified Bundle of Cardioprotective Medications

Bundled cardioprotective medications with simplified delivery reduced the risk of hospitalization for myocardial infarction or stroke among patients at high risk.


R. Adams Dudley, MD, MBA

Latest:

Small Practices' Experience With EHR, Quality Measurement, and Incentives

A study to assess clinician attitudes and experiences after participating in a New York City cardiovascular disease focused quality recognition and financial incentive program using health information technology.


Sarika Ogale, PhD

Latest:

Claims Identification of Patients With Severe Cancer-Related Symptoms

The authors established a claims-based mechanism for identifying patients with lung cancer with more severe patient-reported cancer-related symptoms who could benefit from engagement with health care programs.



Pamela Gray Reger, LCSW

Latest:

Effectiveness of Care Coordination and Health Counseling in Advancing Illness

This prospective trial suggests that specialized care coordination and health counseling for patients coping with advanced stages of 4 life-limiting illnesses can be beneficial.




John F. McAna, PhD

Latest:

A Predictive Model of Hospitalization Risk Among Disabled Medicaid Enrollees

Predictive modeling can be used to identify disabled Medicaid beneficiaries at high risk of future hospitalizations who could benefit from appropriate interventions.


Mohanad AlMahmoud, MD

Latest:

The Association Between Insurance Type and Cost-Related Delay in Care: A Survey

In a survey of patients and visitors to a large academic medical center, middle-income respondents with private insurance reported more cost-related delays in care than those with public insurance.



Qian Shi, PhD, MPH

Latest:

Evaluation of the Quality Blue Primary Care Program on Health Outcomes

Implementation of the Quality Blue Primary Care program in Louisiana was associated with a shift in primary care delivery and reductions in overall cost.



CEO, Federation of American Hospitals

Latest:

Building Upon the Strong Foundation of National Healthcare Quality

Focusing on quality and quality measurements has the potential to reduce costs, increase quality, and deliver more value to patients, consumers, and customers.




Jeff Luck, PhD

Latest:

Can Accountable Care Divert the Sources of Hospitalization?

Oregon’s Medicaid accountable care organizations led to reductions in preventable hospital admissions, especially unscheduled admissions, among female beneficiaries aged 15 to 44 years.



David G. Fairchild, MD, MPH

Latest:

Impact of Cardiac Telemetry on Patient Safety and Cost

Reducing inappropriate use of cardiac telemetry may improve the cost of care while maintaining patient safety.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo